Risks of Long-Term Temazepam Use
Long-term temazepam use carries significant risks including physical dependence with potentially life-threatening withdrawal reactions, increased fall risk (especially in elderly patients), cognitive impairment that persists for months after discontinuation, abuse potential, and substantially higher overdose fatality compared to other benzodiazepines.
Critical Safety Concerns
Dependence and Withdrawal (Highest Priority Risk)
The FDA mandates a black box warning for temazepam regarding dependence and withdrawal reactions 1. Continued use leads to clinically significant physical dependence, and abrupt discontinuation or rapid dose reduction can precipitate acute withdrawal reactions that can be life-threatening 1. Notably, some patients develop a protracted withdrawal syndrome lasting weeks to more than 12 months after stopping 1.
Falls and Physical Impairment
Temazepam causes drowsiness and decreased consciousness, placing patients—particularly the elderly—at substantially higher risk of falls 1. Research demonstrates that withdrawal from long-term temazepam use rapidly improves both handgrip strength and balance within 1-3 weeks, with women showing particularly significant improvements 2. This indicates that chronic use actively impairs physical functioning and fall risk throughout the treatment period.
Cognitive Dysfunction
Long-term temazepam use causes prolonged impairment of attention and psychomotor cognitive functioning that persists for at least 6 months after withdrawal 3. Reaction times remain slower than benzodiazepine-free individuals even after discontinuation, suggesting lasting neurological effects 3.
Overdose Lethality
Temazepam carries 10-13 times higher fatal toxicity in overdose compared to diazepam 4. This makes it particularly dangerous for patients at risk of self-harm or suicidal ideation 4. The FDA label warns that worsening depression and suicidal thinking have been reported in primarily depressed patients using sedative-hypnotics 1.
Additional Documented Risks
Complex Sleep Behaviors
Patients may engage in "sleep-driving" and other complex behaviors (preparing food, making phone calls, having sex) while not fully awake, with no memory of these events 1. This risk increases when combined with alcohol or other CNS depressants 1.
Abuse and Misuse Potential
The FDA requires a black box warning regarding abuse, misuse, and addiction risks 1. Recent pharmacovigilance data identified potential abuse signals and behavioral adverse events including aggression, amnesia, nightmares, and somnambulism 5.
Severe Allergic Reactions
Rare cases of angioedema involving the tongue, glottis, or larynx have been reported, which can cause fatal airway obstruction 1.
Emerging Safety Signals
A 20-year analysis of the FAERS database identified numerous ocular adverse events not on the product label, including eye irritation, increased intraocular pressure, glaucoma, eye inflammation, and photophobia 5.
Dementia Association
Observational data from the American College of Physicians guideline indicates that benzodiazepines are associated with dementia, with the greatest effect seen with higher-dose hypnotics and benzodiazepines with half-lives exceeding 24 hours 6.
Clinical Context from Guidelines
Despite these risks, both the American Academy of Sleep Medicine (2017) and American College of Physicians (2016) provide recommendations for temazepam use, but only for short-term treatment 7. The AASM guideline notes "minimal evidence for harms" but this assessment is based on trials lasting only 2-8 weeks with small sample sizes 7. The guideline explicitly states that hypnotics should ideally be limited to 4 weeks maximum 8.
Key Clinical Pitfalls
- Duration creep: What starts as short-term use often becomes chronic without reassessment
- Elderly patients: Face compounded risks of falls, cognitive impairment, and oversedation—require lower doses (7.5 mg initial) 1
- Combination with opioids: Creates profound respiratory depression risk requiring a separate FDA black box warning 1
- Abrupt discontinuation: Must use gradual taper to prevent potentially fatal withdrawal 1
The evidence clearly demonstrates that long-term temazepam use transforms from a therapeutic intervention into a source of ongoing harm affecting physical function, cognition, safety, and independence—particularly in older adults who comprise the majority of chronic users.